Microbiome of esophageal endoscopic wash samples is associated with resident flora in the esophagus and incidence of cancer.
16S rRNA
Diagnosis
Esophageal carcinoma
Esophageal endoscopic wash
Microbiome
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
22 08 2024
22 08 2024
Historique:
received:
29
03
2024
accepted:
10
07
2024
medline:
23
8
2024
pubmed:
23
8
2024
entrez:
22
8
2024
Statut:
epublish
Résumé
Change in mucosal microbiome is associated with various types of cancer in digestive tract. We hypothesized that microbial communities in the esophageal endoscopic wash fluids reflects resident flora in esophageal mucosa that is associated with esophageal carcinoma (EC) risk and/or directly correlates microbiome derived from EC tumor tissue. Studying microbial communities in esophageal endoscopic wash samples would be therefore useful to predict the incidence or risk of EC. We examined microbial communities of the endoscopic wash samples from 45 primary EC and 20 respective non-EC controls using 16S rRNA V3-V4 amplicon sequencing. The result was also compared with microbial communities in matched endoscopic biopsies from EC and non-cancerous esophageal mucosa. Compared with non-EC controls, 6 discriminative bacterial genera were detected in EC patients. Among them, relative abundance ratio of Prevotella and Shuttlewarthia, as well as decrease of genus Prevotella presented good prognostic performance to discriminate EC from controls (area under curve, 0.86, 0.82, respectively). Multivariate analysis showed occurrence of EC was an independent factor associated with decrease of this bacteria. Abundance of genus Prevotella in the esophageal endoscopic wash samples was significantly correlated with the abundance of this bacteria in the matched endoscopic biopsies from non-cancerous esophageal mucosa but not in the EC tissues. Our findings suggest that microbiome composition in the esophageal endoscopic wash samples reflects resident flora in the esophagus and significantly correlates with the incidence of EC.
Identifiants
pubmed: 39174555
doi: 10.1038/s41598-024-67410-1
pii: 10.1038/s41598-024-67410-1
doi:
Substances chimiques
RNA, Ribosomal, 16S
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
19525Subventions
Organisme : Japan Society for the Promotion of Science London
ID : 22K08089
Informations de copyright
© 2024. The Author(s).
Références
Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin. 71, 209–249 (2021).
pubmed: 33538338
doi: 10.3322/caac.21660
Lagergren, J. et al. Oesophageal cancer. Lancet 2017(390), 2383–2396 (2017).
doi: 10.1016/S0140-6736(17)31462-9
Gavin, A. T. et al. Oesophageal cancer survival in Europe: A EUROCARE-4 study. Cancer Epidemiol. 36, 505–512 (2012).
pubmed: 22910036
doi: 10.1016/j.canep.2012.07.009
Pohl, H. et al. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J. Natl. Cancer Inst. 97, 142–146 (2005).
pubmed: 15657344
doi: 10.1093/jnci/dji024
Everhart, J. E. et al. Burden of digestive diseases in the United States part I: Overall and upper gastrointestinal diseases. Gastroenterology 136, 376–386 (2009).
pubmed: 19124023
doi: 10.1053/j.gastro.2008.12.015
Tachimori, Y. et al. Comprehensive registry of esophageal cancer in Japan, 2006. Esophagus. 11, 21–47 (2014).
doi: 10.1007/s10388-013-0393-5
Masuda, M. et al. Thoracic and cardiovascular surgery in Japan during 2012: Annual report by The Japanese Association for thoracic surgery. Gen. Thorac. Cardiovasc. Surg. 62, 734–764 (2014).
pubmed: 25355583
pmcid: 4254159
doi: 10.1007/s11748-014-0464-0
Ohashi, S. et al. Recent advances from basic and clinical studies of esophageal squamous cell carcinoma. Gastroenterology 149, 1700–1715 (2015).
pubmed: 26376349
doi: 10.1053/j.gastro.2015.08.054
Caygill, C. P. et al. Mortality in Barrett’s esophagus: Three decades of experience at a single center. Endoscopy 44, 892–898 (2012).
pubmed: 22752886
doi: 10.1055/s-0032-1309842
Rostami, N. M. et al. The role of infectious mediators and gut microbiome in the pathogenesis of celiac disease. Arch. Iran Med. 18, 244–249 (2015).
pubmed: 25841946
Ohkusa, T. et al. Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut 52, 79–83 (2003).
pubmed: 12477765
pmcid: 1773498
doi: 10.1136/gut.52.1.79
Kostic, A. D. et al. The microbiome in inflammatory bowel disease: Current status and the future ahead. Gastroenterology 146, 1489–1499 (2014).
pubmed: 24560869
doi: 10.1053/j.gastro.2014.02.009
Ley, R. E. et al. Microbial ecology: Human gut microbes associated with obesity. Nature 444, 1022–1023 (2006).
pubmed: 17183309
doi: 10.1038/4441022a
Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860–867 (2006).
pubmed: 17167474
doi: 10.1038/nature05485
Cani, P. D. et al. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 3, 279–288 (2012).
pubmed: 22572877
pmcid: 3463487
doi: 10.4161/gmic.19625
Fujimura, K. E. et al. Microbiota in allergy and asthma and the emerging relationship with the gut microbiome. Cell Host Microbe 17, 592–602 (2015).
pubmed: 25974301
pmcid: 4443817
doi: 10.1016/j.chom.2015.04.007
Vogtmann, E. et al. Epidemiologic studies of the human microbiome and cancer. Br J Cancer 114, 237–242 (2016).
pubmed: 26730578
pmcid: 4742587
doi: 10.1038/bjc.2015.465
Garrett, W. S. Cancer and the microbiota. Science 348, 80–86 (2015).
pubmed: 25838377
pmcid: 5535753
doi: 10.1126/science.aaa4972
Castellarin, M. et al. Fusobacterium nucleatum infection is prevalent inhuman colorectal carcinoma. Genome Res. 22, 299–306 (2012).
pubmed: 22009989
pmcid: 3266037
doi: 10.1101/gr.126516.111
Kostic, A. D. et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14, 207–215 (2013).
pubmed: 23954159
pmcid: 3772512
doi: 10.1016/j.chom.2013.07.007
Rubinstein, M. R. et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its fadA adhesin. Cell Host Microbe 14, 195–206 (2013).
pubmed: 23954158
pmcid: 3770529
doi: 10.1016/j.chom.2013.07.012
Clay, S. L. et al. Colorectal cancer: The facts in the case of the microbiota. J. Clin. Invest. 132, e155101 (2022).
pubmed: 35166235
pmcid: 8843708
doi: 10.1172/JCI155101
Peters, B. A. et al. Oral microbiome composition reflects prospective risk for esophageal cancers. Cancer Res. 77, 6777–6787 (2017).
pubmed: 29196415
pmcid: 5726431
doi: 10.1158/0008-5472.CAN-17-1296
Yu, G. et al. Association between upper digestive tract microbiota and cancer-predisposing states in the esophagus and stomach. Cancer Epidemiol. Prev. Biomark. 23, 735–741 (2014).
doi: 10.1158/1055-9965.EPI-13-0855
Yamamura, K. et al. Human microbiome Fusobacterium nucleatum in esophageal cancer tissue is associated with prognosis. Clin. Cancer Res. 22(22), 5574–5581 (2016).
pubmed: 27769987
doi: 10.1158/1078-0432.CCR-16-1786
Zhu, H. et al. Convergent dysbiosis of upper aerodigestive microbiota between patients with esophageal and oral cavity squamous cell carcinoma. Int. J. Cancer. 152, 1903–1915 (2023).
pubmed: 36752573
doi: 10.1002/ijc.34460
Watanabe, Y. et al. Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes. Gastroenterology 136, 2149–2158 (2009).
pubmed: 19375421
doi: 10.1053/j.gastro.2009.02.085
Vadhwana, B. et al. Evaluation of the oesophagogastric cancer-associated microbiome: A systematic review and quality assessment. Cancers (Basel) 15, 2668 (2023).
pubmed: 37345006
doi: 10.3390/cancers15102668
Li, Z. et al. Characterization of the oral and esophageal microbiota in esophageal precancerous lesions and squamous cell carcinoma. Front Cell Infect Microbiol. 11, 714162 (2021).
pubmed: 34604107
pmcid: 8479167
doi: 10.3389/fcimb.2021.714162
Zhang, S. et al. Intratumoral microbiome impacts immune infiltrates in tumor microenvironment and predicts prognosis in esophageal squamous cell carcinoma patients. Front. Cell Infect. Microbiol. 13, 1165790 (2023).
pubmed: 37180444
pmcid: 10174428
doi: 10.3389/fcimb.2023.1165790
Chen, X. et al. Oral microbiota and risk for esophageal squamous cell carcinoma in a high-risk area of China. PLoS One 10, e0143603 (2015).
pubmed: 26641451
pmcid: 4671675
doi: 10.1371/journal.pone.0143603
Nishijima, S. et al. The gut microbiome of healthy Japanese and its microbial and functional uniqueness. DNA Res. 23, 125–133 (2016).
pubmed: 26951067
pmcid: 4833420
doi: 10.1093/dnares/dsw002
Abnet, C. C. et al. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology 154, 360–373 (2018).
pubmed: 28823862
doi: 10.1053/j.gastro.2017.08.023
Murphy, G. et al. International cancer seminars: A focus on esophageal squamous cell carcinoma. Ann. Oncol. 28, 2086–2093 (2017).
pubmed: 28911061
pmcid: 5834011
doi: 10.1093/annonc/mdx279
Sheikh, M. et al. Individual and combined efects of environmental risk factors for esophageal cancer based on results from the Golestan Cohort Study. Gastroenterology 156, 1416–1427 (2019).
pubmed: 30611753
doi: 10.1053/j.gastro.2018.12.024
Spechler, S. J. et al. American Gastroenterological Association. American Gastroenterological Association, American Gastroenterological Association technical review on the management of Barrett’s esophagus. Gastroenterology 140, e18–e52 (2011).
pubmed: 21376939
doi: 10.1053/j.gastro.2011.01.031
Li, W. et al. Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study. Respir. Res. 23, 321 (2022).
pubmed: 36403054
pmcid: 9675190
doi: 10.1186/s12931-022-02246-9
Ramsheh, M. Y. et al. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis. Lancet Microbe 2, e300–e310 (2021).
pubmed: 35544166
doi: 10.1016/S2666-5247(21)00035-5
Merlo, J. R. et al. Chronic obstructive pulmonary disease, part 1: Disease state review. Sr. Care Pharm. 38, 214–222 (2023).
pubmed: 37231577
doi: 10.4140/TCP.n.2023.214
Yokoyama, A. et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature 565, 312–317 (2019).
pubmed: 30602793
doi: 10.1038/s41586-018-0811-x
Moody, S. et al. Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence. Nat. Genet. 53, 1553–1563 (2021).
pubmed: 34663923
doi: 10.1038/s41588-021-00928-6
Baba, Y. et al. Relationship between gut microbiome Fusobacterium nucleatum and LINE-1 methylation level in esophageal cancer. Esophagus 20, 704–712 (2023).
pubmed: 37173453
doi: 10.1007/s10388-023-01009-9
Tahara, T. et al. Fusobacterium in colonic flora and molecular features of colorectal carcinoma. Cancer Res. 74, 1311–1318 (2014).
pubmed: 24385213
pmcid: 4396185
doi: 10.1158/0008-5472.CAN-13-1865